Thu, 06th Feb 2014 12:50
UK stocks rose again on Tuesday as the Santa Rally continued into its sixth straight day, with markets boosted by some upbeat economic data from the States. Third-quarter US annualised gross domestic product (GDP) growth was revised to 5% from an initial estimate of 3.9%, representing the strongest
Read moreUK stocks rose again on Tuesday as the pre-Christmas rally continued, though gains were trimmed by lunchtime after some disappointing data. On a day lacking of corporate news, investors were also showing caution ahead of a flurry of economic indicators Stateside. Stock futures on Wall Street were on
Read moreCameroon-focused oil explorer Bowleven has allowed extra time for the completion of the farm-out agreement over its Etinde project as it continued to sweat over presidential approval. Having in October said the only remaining formality to the completion of the transaction was the gazetting of the si
Read moreAn estimated 2,000 insurance jobs are likely to be axed as Aviva tries to placate scepticism about its bid for Friends Life. While some analysts hailed the £5.6bn deal announced on Friday evening as giving Aviva scope to push up its dividend, others were unimpressed, with one questioning whether it
Read moreWesthouse Securities has called for investors in the oil and gas sector to be a "bit more patient" with oil prices currently rumbling along at multi-year lows, as it highlighted buying opportunities in the sector. Brent crude has now fallen over 25% to $79 a barrel since hitting a high of $115 a bar
Read moreAstraZeneca: JP Morgan raises target price from 3700p to 4100p, keeping its underweight rating. AVEVA Group: Barclays upgrades to overweight. Bellway: Credit Suisse raises target price from 1876p to 1905p and keeps a neutral rating. Bow Leven: Barclays shifts target price from 45p to 50p and retai
Read more